C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2006
11/30/2006	CA2608375A1 Organic compounds for the treatment of inflammatory or alleric conditions
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725518A1 Pharmaceutical compounds
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725102A1 Hiv integrase inhibitors
11/29/2006	EP1177182B1 Novel photoinitiators and their applications
11/29/2006	EP1092027B1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	EP0864648B1 Method for screening compounds regulating the expression of human-inducible nitric oxide synthase
11/29/2006	EP0738149B1 1-aminoindan derivatives and compositions thereof
11/29/2006	CN1871225A Preferentially substituted calcium channel blockers
11/29/2006	CN1871216A Inhibitors of cathepsin s
11/29/2006	CN1869002A Class I non-steroid androgen acceptor regulator, its preparation method and use
11/29/2006	CN1286825C Method for preparing N-amino propyl morpholine
11/29/2006	CN1286805C Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
11/28/2006	US7141595 Amino benzothiazole compounds with NOS inhibitory activity
11/28/2006	US7141573 Huntington's diseases, Alzheimer's diseases, psychological disorders
11/28/2006	US7141560 For use as analgesic or sedative; treating sleep disorders
11/28/2006	US7141312 Narrow emission bands, low driver voltages, high photometric efficiency and high thermal stability within a broad spectral range; 2,5-bis-(N-(2,4-dimethoxyphenyl)amino)terephthalic acid diethyl ester for example
11/23/2006	WO2006125194A2 Piperazine derivatives and their uses as therapeutic agents
11/23/2006	WO2006124865A2 Biaryls derivatives useful as modulators of ion channels
11/23/2006	WO2006123244A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	WO2006123020A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/23/2006	WO2006122546A1 Non-peptidic inhibitors of akap/pka interaction
11/23/2006	WO2006061372A3 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264435 Novel compounds
11/23/2006	CA2611896A1 Non-peptidic inhibitors of akap/pka interaction
11/23/2006	CA2609161A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/22/2006	EP1724256A2 Novel process for the synthesis of 5-(4-fluorphenyl)-1-2(2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
11/22/2006	EP1723955A1 Medicine for prevention and/or treatment of ischemic circulatory disease
11/22/2006	EP1723164A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
11/22/2006	EP1722827A2 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	EP1120114B1 Compositions and methods for treating conditions responsive to estrogen
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	CN1867554A Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors
11/22/2006	CN1867539A Method for the distillative separation of mixtures containing ethyleneamines
11/22/2006	CN1865253A Repaglinide synthesis process
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138418 Pentafluorobenzenesulfonamides and analogs
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138407 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/21/2006	CA2158060C Process for the preparation of .beta.-phenylisoserine derivatives
11/21/2006	CA2120619C Novel potent inducers of terminal differentiation and methods of use thereof
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	WO2006120178A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes
11/16/2006	WO2006083924A8 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	US20060258866 Carboxylic derivates
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258684 2-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl]ethoxy]acetic acid monohydrochloride as anti-allergenic compound and process for its production
11/16/2006	US20060258683 Para-sulfonyl substituted phenyl compounds as modulators of ppars
11/16/2006	US20060257579 Use of a salt of a poly-acid to delay setting in cement slurry
11/16/2006	CA2598365A1 Analogs of 4-hydroxyisoleucine and uses thereof
11/15/2006	EP1720861A2 Histamine h3 receptor antagonists, preparation and therapeutic uses
11/15/2006	EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720825A1 New compounds, methods for their preparation and use thereof
11/15/2006	EP1474127B1 Biphenyl derivatives and their use as antiandrogenic agents
11/15/2006	CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/14/2006	US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006	US7135502 Colchinol derivatives as vascular damaging agents
11/14/2006	US7135487 Sulphonamide derivatives
11/14/2006	US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135047 N-2-(morpholine-4-yl)ethyl-m-phenylenediamine, N-3-(morpholine-4-yl)propyl-m-phenylenediamine, and N-3-(imidazole-1-yl)-propyl-m-phenylenediamine; high color intensities, good light fastness and washing fastness properties, and a good equalization capability
11/14/2006	CA2294783C Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
11/14/2006	CA2267376C Process for producing depsipeptide derivatives and novel intermediates therefor
11/14/2006	CA2171836C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
11/14/2006	CA2156432C New derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning
11/09/2006	WO2006117669A1 Amide resorcinol compounds
11/09/2006	WO2006117611A1 Histamine h3-recept0r ligands and their therapeutic application
11/09/2006	WO2006117609A2 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands
11/09/2006	WO2006117549A1 Enzyme inhibitors
11/09/2006	WO2005074603A3 Aminobenzoxazoles as therapeutic agents
11/09/2006	US20060252934 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents
11/09/2006	US20060252832 Derivatives of acanthoic and kauranoic acid; treatment of cachexia' cardiovascular disease, otitis media, sinusitis and transplant; anti-inflammatory, diabetic and cancer agents
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252753 N-methyl-N-[2-( 1-pyrrolidinyl)cyclohexyl]-3,4-dichlorocinnamide monohydrochloride;
11/09/2006	US20060252647 Herbicides; broad active spectrum; on soil and above ground plant parts use
11/09/2006	CA2606269A1 Histamine h3-recept0r ligands and their therapeutic application
11/09/2006	CA2606262A1 Novel histamine h3-receptor ligands and their therapeutic applications
11/09/2006	CA2605985A1 Amide resorcinol compounds
11/09/2006	CA2599411A1 Enzyme inhibitors
11/08/2006	EP1719529A1 Contrast medium for thrombus formation
11/08/2006	EP1718628A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
11/08/2006	EP1718627A1 Process for preparing optically active cetirizine or its salt
11/08/2006	EP1718307A2 Immunosuppressant compounds and compositions
11/08/2006	EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/08/2006	EP0893432B1 Phenylethanolaminotetralincarboxamide derivatives
11/08/2006	CN1859904A Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
11/08/2006	CN1858038A Oxo fluoroalkyl sulfamide compound and its preparing method and use
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283632C Process for preparing N-acetyl morpholine

1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 341